Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML

Author： Cortes Jorge E.   Goldberg Stuart L.   Feldman Eric J.   Rizzeri David A.   Hogge Donna E.   Larson Melissa   Pigneux Arnaud   Recher Christian   Schiller Gary   Warzocha Krzysztof   Kantarjian Hagop   Louie Arthur C.   Kolitz Jonathan E.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|2|234-242

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.2, 2015-01, pp. : 234-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer

By Madajewicz Stefan  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 772-778

Springer Publishing Company

Access to resources Recommend Favorite

Liposomal daunorubicin + cytarabine effective in AML

By  

Inpharma, Vol. 1, Iss. 1304, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Cytarabine/daunorubicin: First report of thyroid storm: case report

By  

Reactions Weekly, Vol. 1, Iss. 1059, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Cytarabine/daunorubicin: Gastrointestinal disorders (first report of daunorubicin in ileitis and colitis): 5 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1399, 2012-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite

Cytarabine/daunorubicin: Aortic thrombosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1429, 2012-01 ,pp. : 14-15

Adis International

Access to resources Recommend Favorite